Study on immune inflammatory injury and pathogenesis of Sjogren's syndrome and systemic lupus erythematosus

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040237

Enrollment

Unknown

Registered

2020-11-25

Start date

2020-11-14

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune disease

Interventions

Two groups:NA

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with clinical diagnosis of SS or SLE

Exclusion criteria

Exclusion criteria: Tumor, drug-induced lupus and other related lesions

Design outcomes

Primary

Measure	Time frame
ANA;ENA;	—

Countries

China

Contacts

Public ContactZhang Naidan

Deyang People's Hospital

znd1984@126.com+86 15883444219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026